ArticleFrontiers in immunology2025

Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010-2025.

Wensheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.